ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Notch signaling mutations increase intra-tumor chemokine expression and predict response to immunotherapy in colorectal cancer

Wang, Fei; Huang, Chuan; Long, Jie; Zhao, Zhi-Bin; Ma, Hai-Qing*; Yao, Xue-Qing*; Li, Liang*; Lian, Zhe-Xiong广东省人民医院; 广东省心血管病研究所
BMC CANCER2022-8-29DOI: 10.1186/s12885-022-10032-5
8被引9阅读
引用收藏
分享

摘要

Background The Notch signaling mutation is associated with enhanced anti-tumor immune response in colorectal cancer (CRC). In this study, we aim to investigate the underlying mechanism and the predictive potential of Notch signaling mutation for responding to immunotherapy in CRC. Methods We analyzed the immune response associated genes in CRC with Notch signaling mutation concomitant with or without microsatellite instability (MSI) using TCGA dataset and investigated the mutation profiles of the Notch signaling pathway using cBioPortal. The Notch signaling scores and immune cell infiltration scores in different groups were calculated. We applied the Kaplan-Meier method for survival analysis in CRC patients who underwent immunotherapy, and the log-rank test to determine the statistically significant differences in survival. Notch1-knock-down cell line was constructed to detect the pathway and gene variations. Results We found that Notch signaling pathway mutation was associated with activated immune response, especially in those with MSI. Such association is useful for predicting a prolonged overall survival of CRC patients who underwent immune checkpoint inhibitor treatment. The mutation resulted in the functional loss of Notch signaling and may modulate the tumor immune microenvironment by increasing the expression of chemokines that are important for recruiting immune cells. Conclusions The Notch signaling mutation can modulate the chemotaxis of immune cells by upregulating the chemokine levels of the tumor immune microenvironment, and CRC patients with Notch signaling pathway mutation have better overall survival after immune checkpoint inhibitor treatment.

学科与关键词

关键词
Colorectal cancerNotch signalingMutationImmunotherapyChemokine
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
BMC CANCER
发表日期
2022-08-29
卷期
第 22 卷, 第 1 期
页码
933
DOI
10.1186/s12885-022-10032-5
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [82120108013, 82072719, 32100720]; Guangdong Academy of Medical Sciences [DFJH201913]; Science and Technology Planning Project of Ganzhou [202101074816]; Program for Guangdong Introducing Innovative and Entrepreneurial Teams [2017ZT07S054]

作者

  • W

    Wang, Fei (第一作者)

    guangdong prov peoples hosp · guangdong cardiovasc inst

  • H

    Huang, Chuan

查看全部 8 位作者收起作者
  • L

    Long, Jie

    guangdong cardiovasc inst · guangdong prov peoples hosp

  • Z

    Zhao, Zhi-Bin

    guangdong prov peoples hosp

  • M

    Ma, Hai-Qing (通讯)

    guangdong prov peoples hosp

  • Y

    Yao, Xue-Qing (通讯)

    guangdong prov peoples hosp

  • L

    Li, Liang (通讯)

    guangdong prov peoples hosp

  • L

    Lian, Zhe-Xiong

    guangdong prov peoples hosp · guangdong cardiovasc inst

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417